These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 32112716)
21. Management of Antithrombin Deficiency in Pregnancy. Hart C; Rott H; Heimerl S; Linnemann B Hamostaseologie; 2022 Oct; 42(5):320-329. PubMed ID: 36323279 [TBL] [Abstract][Full Text] [Related]
22. Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis. Akinshina S; Makatsariya A; Bitsadze V; Khizroeva J; Khamani N J Perinat Med; 2018 Oct; 46(8):893-899. PubMed ID: 29949514 [TBL] [Abstract][Full Text] [Related]
23. [INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA]. Neikova K ; Dimitrova V; Dimitrov R; Savov A Akush Ginekol (Sofiia); 2015; 54(5):3-12. PubMed ID: 26411189 [TBL] [Abstract][Full Text] [Related]
24. Comparison of Continuation of Low-Molecular-Weight Heparin versus Switching to Unfractionated Heparin in the Peripartum. Enakpene CA; Pontarelli KN; Della Torre M Am J Perinatol; 2020 Feb; 37(3):304-312. PubMed ID: 30818404 [TBL] [Abstract][Full Text] [Related]
25. Thrombin generation and low-molecular-weight heparin prophylaxis in pregnant women with thrombophilia. Selmeczi A; Roach RE; Móré C; Batta Z; Hársfalvi J; van der Bom JG; Boda Z; Oláh Z Thromb Haemost; 2015 Feb; 113(2):283-9. PubMed ID: 25392852 [TBL] [Abstract][Full Text] [Related]
26. Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy. Alguel G; Vormittag R; Simanek R; Kyrle PA; Quehenberger P; Mannhalter C; Husslein P; Pabinger I Thromb Haemost; 2006 Sep; 96(3):285-9. PubMed ID: 16953268 [TBL] [Abstract][Full Text] [Related]
27. THE ROLE OF LOW MOLECULAR WEIGHT HEPARIN IN WOMEN WITH HEREDITARY THROMBOPHILIA FOR GOOD PERINATAL OUTCOME. Sokol V; Ivanišević M; Herman M; Đelmiš J Acta Clin Croat; 2016 Jun; 55(2):309-15. PubMed ID: 28394549 [TBL] [Abstract][Full Text] [Related]
28. Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview. Bates SM; Alonso-Coello P; Tikkinen KA; Ebrahim S; Lopes LC; McDonald SD; Zhou Q; Akl EA; Neumann I; Jacobsen AF; Zhang Y; Santamaría A; Annichino-Bizzacchi JM; Sandset PM; Bitar W; Eckman MH; Guyatt GH Thromb Res; 2016 Apr; 140():22-9. PubMed ID: 27500301 [TBL] [Abstract][Full Text] [Related]
29. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis. Friederich PW; Sanson BJ; Simioni P; Zanardi S; Huisman MV; Kindt I; Prandoni P; Büller HR; Girolami A; Prins MH Ann Intern Med; 1996 Dec; 125(12):955-60. PubMed ID: 8967705 [TBL] [Abstract][Full Text] [Related]
30. Hereditary antithrombin deficiency in pregnancy - severe thrombophilic disorder as a danger for mother and foetus. Čápová Irena; Salaj Peter; Hrachovinová Ingrid Ceska Gynekol; 2021; 86(3):175-182. PubMed ID: 34167310 [TBL] [Abstract][Full Text] [Related]
31. Thrombophilia and pregnancy complications. Vormittag R; Pabinger I Hamostaseologie; 2006 Jan; 26(1):59-62. PubMed ID: 16444325 [TBL] [Abstract][Full Text] [Related]
32. Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications. Kraft J; Sunder-Plassmann R; Mannhalter C; Quehenberger P; Tews G; Langer M; Pabinger I Ann Hematol; 2017 Jun; 96(6):1023-1031. PubMed ID: 28361296 [TBL] [Abstract][Full Text] [Related]
33. Inherited antithrombin deficiency and pregnancy: maternal and fetal outcomes. Sabadell J; Casellas M; Alijotas-Reig J; Arellano-Rodrigo E; Cabero L Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):47-51. PubMed ID: 20047788 [TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism in pregnancy: diagnosis, management and prevention. Chunilal SD; Bates SM Thromb Haemost; 2009 Mar; 101(3):428-38. PubMed ID: 19277402 [TBL] [Abstract][Full Text] [Related]
35. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review. Duhl AJ J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817 [TBL] [Abstract][Full Text] [Related]
36. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism. Chai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Zdraveska M; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M; Am J Med; 2018 Apr; 131(4):430-437. PubMed ID: 29274307 [TBL] [Abstract][Full Text] [Related]
37. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis. Jørgensen M; Broholm R; Bækgaard N Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532 [TBL] [Abstract][Full Text] [Related]
38. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Folkeringa N; Brouwer JL; Korteweg FJ; Veeger NJ; Erwich JJ; Holm JP; van der Meer J Br J Haematol; 2007 Feb; 136(4):656-61. PubMed ID: 17223916 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy. Ní Ainle F; Wong A; Appleby N; Byrne B; Regan C; Hassan T; Milner M; Sullivan AO; White B; O'Donnell J Blood Coagul Fibrinolysis; 2008 Oct; 19(7):689-92. PubMed ID: 18832911 [TBL] [Abstract][Full Text] [Related]
40. Inherited thrombophilia and venous thromboembolism. Greer IA Best Pract Res Clin Obstet Gynaecol; 2003 Jun; 17(3):413-25. PubMed ID: 12787535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]